Citation Impact
Citing Papers
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic
2009 StandoutNature
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
2010
Virosome influenza vaccine in children
2002
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
2005
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals
2003
Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine
2004
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
2005 Standout
Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission
2004
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Influenza-Associated Hospitalizations in the United States
2004 Standout
The Relationship of Fall School Opening and Emergency Department Asthma Visits in a Large Metropolitan Area
2005
Global trends in emerging infectious diseases
2008 StandoutNature
Detecting influenza epidemics using search engine query data
2008 StandoutNature
Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience
2001
Psychological Stress and Susceptibility to the Common Cold
1991 Standout
Transmission and control of rhinovirus colds
1987
Transmission and Clinical Features of Enterovirus 71 Infections in Household Contacts in Taiwan
2004
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents
2004
Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent
2003
Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults
2000
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
2007 Standout
Review Article
2015
Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza
2003
Strategies for containing an emerging influenza pandemic in Southeast Asia
2005 StandoutNature
Comparison of Heterotypic Protection against Influenza A/Taiwan/86 (H1N1) by Attenuated and Inactivated Vaccines to A/Chile/83-like Viruses
1991
The Burden of Respiratory Syncytial Virus Infection in Young Children
2009 Standout
Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
2006
Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophylaxis
2004
Zanamivir Prophylaxis: An Effective Strategy for the Prevention of Influenza Types A and B within Households
2002
Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households
2003
Adenovirus-mediated Expression of Aquaporin-5 in Epithelial Cells
1996 StandoutNobel
Mucosal immunity and vaccines
2005 Standout
Transmissibility and transmission of respiratory viruses
2021
Respiratory virus shedding in exhaled breath and efficacy of face masks
2020 Standout
Multiple sclerosis
2008 Standout
NF-κB: Ten Years After
1996 StandoutNobel
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
2011
The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children
1998
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
The burden of influenza illness in children with asthma and other chronic medical conditions
2000
The Epidemiology of Acute Respiratory Tract Infection in Young Children: Comparison of Findings from Several Developing Countries
1990
Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young Children
2000
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
2004 Standout
Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
1994
Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children
2001
Strategy for Distribution of Influenza Vaccine to High-Risk Groups and Children
2005
Type 1 diabetes
2013 Standout
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
1998 Standout
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Strategies for mitigating an influenza pandemic
2006 StandoutNature
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
2000
Does Medicare Save Lives?*
2009 StandoutNobel
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Epidemiology of Multiple Sclerosis: A Critical Overview
1993
The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly
2005
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls
1999 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
A newly discovered human pneumovirus isolated from young children with respiratory tract disease
2001 Standout
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
2004 Standout
The treatment of rhinovirus infections: progress and potential
2001
The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in Children
2000
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Rotavirus Infection in Infants as Protection against Subsequent Infections
1996 Standout
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
2009
Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial
2000
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Influenza Virus Infection in Travelers to Tropical and Subtropical Countries
2005
Influenza Vaccination in Children with Asthma
2003
Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial
2005
Approximate Inference in Generalized Linear Mixed Models
1993 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Effect of adenovirus resistance on UV disinfection requirements: A report on the state of adenovirus science
2006
Prevention and Control of Seasonal Influenza with Vaccines
2016
Indirect standardization and multiplicative models for rates, with reference to the age adjustment of cancer incidence and relative frequency data
1975
Quantifying the Impact of Human Mobility on Malaria
2012 StandoutScience
Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies
2011
Systems to rate the strength of scientific evidence.
2002
Aging and Health: Effects of the Sense of Control
1986 StandoutScience
Prevalence and Quantitation of Species C Adenovirus DNA in Human Mucosal Lymphocytes
2002
Epidemiologic evidence for multiple sclerosis as an infection
1993
Gastroenteritis associated with enteric type adenovirus in hospitalized infants
1982
The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein
2007
Characteristics of Noncultivable Adenoviruses Associated with Diarrhea in Infants: A New Subgroup of Human Adenoviruses
1979
ESTIMATING HOUSEHOLD AND COMMUNITY TRANSMISSION PARAMETERS FOR INFLUENZA
1982
Incidence of Outpatient Visits and Hospitalizations Related to Influenza in Infants and Young Children
2004
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Efficacy of Inactivated Vaccine in Preventing Antigenically Drifted Influenza Type A and Well-Matched Type B
1994
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
2010
OUTBREAK OF INFANTILE GASTROENTERITIS DUE TO TYPE 40 ADENOVIRUS
1983 Standout
Epidemic processes in complex networks
2015 Standout
Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens.
1986 StandoutNobel
Science and technology for water purification in the coming decades
2008 StandoutNature
Potential Cost Savings Attributable to Influenza Vaccination of School-aged Children
1999
Cost-effectiveness of influenza vaccination in high-risk children in Argentina
2001
Safety of the Trivalent, Cold-Adapted Influenza Vaccine in Preschool-Aged Children
2002
The Economic Impact of Pandemic Influenza in the United States: Priorities for Intervention
1999
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Impact of type A influenza on children: a retrospective study.
1982
A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum
1987 StandoutNobel
Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice
2013 StandoutNobel
Cost-Effectiveness Analysis of an Intranasal Influenza Vaccine for the Prevention of Influenza in Healthy Children
2001
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
An ELISA for the detection of rhinovirus specific antibody in serum and nasal secretion
1987
Pediatric viral gastroenteritis during eight years of study
1983
Airborne transmission of respiratory viruses
2021 StandoutScience
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Respiratory Syncytial Virus Infections within Families
1976
Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention.
1996
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Potential Effect of Self-Care Algorithms on the Number of Physician Visits
1979
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of CARRIE E. HALL being referenced
Epidemiology: Man and Disease
1970
THE VIRUS WATCH PROGRAM: A CONTINUING SURVEILLANCE OF VIRAL INFECTIONS IN METROPOLITAN NEW YORK FAMILIES
1969
INFLUENZAVIRUS INFECTIONS IN SEAVFLE FAMILIES, 1975–1979
1982
THE VIRUS WATCH PROGRAM: A CONTINUING SURVEILLANCE OF VIRAL INFECTIONS IN METROPOLITAN NEW YORK FAMILIES
1971
RHINOVIRUSES IN SEATTLE FAMILIES, 1975–1979
1985
THE VIRUS WATCH PROGRAM: A CONTINUING SURVEILLANCE OF VIRAL INFECTIONS IN METROPOLITAN NEW YORK FAMILIES
1969
THE SEATTLE VIRUS WATCH
1977
THE SEATTLE VIRUS WATCH1
1975
THE SEATTLE VIRUS WATCH
1973
INFLUENZAVIRUS INFECTIONS IN SEATTLE FAMILIES, 1975–1979
1982
THE SEATTLE VIRUS WATCH
1975
THE SEATTLE VIRUS WATCH: II. OBJECTIVES, STUDY POPULATION AND ITS OBSERVATION, DATA PROCESSING AND SUMMARY OF ILLNESSES1
1972